News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies
Vivek Subbiah/LinkedIn
Apr 19, 2025, 08:05

Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on LinkedIn about recent paper he and his colleagues co-authored:

“Delighted to share our latest publication in American Society of Clinical Oncology (ASCO) Journal JCO Precision Oncology – courtesy of our brilliant colleagues from London led by Dr. Elisa Fontana.

FGFR is clearly a tissue-agnostic target but we need to find the right dose for the right patient with right alteration.

Thrilled to collaborate with amazing colleagues Tobias Arkenau, Charles Swanton.”

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials

Authors: Rafael Grochot, Tobias Arkenau, Charles Swanton, Vivek Subbiah, Elisa Fontana, et al.

Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies

More posts featuring Vivek Subbiah.

cancer Cancer research Charles Swanton Elisa Fontana OncoDaily Oncology Tobias Arkenau Vivek Subbiah
Special Coverage
Voices
Aug 24, 2025, 13:07
Sebastian Szmit: Two New Important Patrons of The Summit on Cardio-Oncology Excellence 2025
Science
Aug 24, 2025, 12:44
Patrick Hwu: How Can We Make CAR-NK Cell Therapy More Effective Against Tough Cancers?
Societies
Aug 24, 2025, 12:40
Understanding Leptomeningeal Metastatic Disease - WeTrials
Voices
Aug 24, 2025, 12:35
FDA Begins Real-Time Reporting of Adverse Event Data
Opinion
Aug 24, 2025, 12:33
Douglas Flora: Promise of MRD Testing in GI Cancers
Voices
Aug 24, 2025, 12:08
Alique Topalian: CancerCon 2025 Opening Keynote
Insight
Aug 24, 2025, 11:58
Fawzi Abu Rous: Recent Innovative FDA Approvals in Lung Cancer
Voices
Aug 24, 2025, 11:46
Eric Bouffet: Running for Childhood Cancer Support with GFAOP on September 28
OncoDaily Pulse
Aug 24, 2025, 11:32
Yu-Wei Chen: Meet the Experts of VIRO 2025
Voices
Aug 24, 2025, 11:25
David Skorton Shared a Study on Mortality Disparities Among Women Physicians
OncoDaily Pulse
Aug 24, 2025, 11:24
Yousef Zakharia: Meet the Experts of VIRO 2025
Insight
Aug 24, 2025, 11:21
Gustave Roussy Research Shares a Study on TALAPRO-2 as a New Standard of Care in mCRPC